The E7 oncoprotein of high-risk human papillomavirus type 16 enters the nucleus via a nonclassical Ran-dependent

Michael Angeline1, Eric Merle, Junona Moroianu

  • 1Biology Department, Boston College, Chestnut Hill, MA 02467, USA.

Virology
|December 17, 2003
PubMed

Insights

The human papillomavirus (HPV) type 16 E7 oncoprotein enters the nucleus through a unique, nonclassical pathway. This import mechanism is Ran-dependent but bypasses conventional import receptors.

Area of Science:

  • Molecular Biology
  • Virology
  • Cell Biology

Background:

  • High-risk human papillomavirus (HPV) oncoproteins, like HPV16 E7, are crucial for viral transformation.
  • HPV16 E7 targets tumor suppressor proteins such as retinoblastoma protein (pRb) and its relatives (p107, p130).
  • HPV16 E7 functions as a nuclear protein but lacks a typical nuclear localization signal, raising questions about its nuclear import mechanism.

Purpose of the Study:

  • To investigate the nuclear import pathway of the HPV16 E7 oncoprotein.
  • To determine if pRb binding is necessary for E7 nuclear import.
  • To characterize the specific import pathway utilized by HPV16 E7.

Main Methods:

  • Utilized digitonin-permeabilized HeLa cells to study nuclear import.
  • Employed a pRb-binding defective E7 variant (E7(DeltaDLYC)) to assess the role of pRb.
  • Investigated the involvement of Ran and classical importin pathways (Kap alpha2beta1, Kap beta1, Kap beta2).
  • Tested the effect of a dominant-negative Ran mutant (RanG19V-GTP) on E7 nuclear import.

Main Results:

  • HPV16 E7 nuclear import occurred independently of its ability to bind pRb.
  • E7 was imported into the nucleus even when pRb binding was abolished.
  • Nuclear import of E7 was found to be Ran-dependent.
  • E7 import was not inhibited by RanG19V-GTP, indicating it does not use the canonical Kap beta-mediated pathways.
  • The data suggest a novel, nonclassical nuclear import pathway for HPV16 E7.

Conclusions:

  • HPV16 E7 utilizes a novel, nonclassical nuclear import pathway.
  • This pathway is distinct from those mediated by major importin-beta family members.
  • The nuclear import of E7 is Ran-dependent but independent of classical importin receptors.

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...